Google's DeepMind leads the market with Gemini, TPU chips, and cloud growth, making its valuations compelling compared to its ...
Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...
Google is establishing a team to build AI that can simulate the physical world, led by one of the former co-leads on OpenAI's Sora model.
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...
The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.
Google DeepMind, formed in 2023 from a merger of Google's DeepMind team and the Google Brain team from Google Research, is the AI R&D division behind many of Google's more recent AI product ...
There's not enough human-generated data to keep AI models improving at the same rate. 2025 will put a new solution to the test.
The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with the federal government and come up with ways to limit their models’ biases ...
As it looks to accelerate the pace of its AI development, Google is further streamlining the teams building its AI services, platforms, and tools. On Thursday, Logan Kilpatrick, who leads product ...